Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Relieving Opioid-Induced Constipation (OIC) in Patients With Cancer-Related Pain

NCT01384292 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01384292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01384292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Relieving Opioid-Induced Constipation (OIC) in Patients With Cancer-Related Pain
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2011
Completion date
September 30, 2012
Enrollment
14 (actual)
Sites
140

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-induced constipation